Moving forward once PP closes, Ball is in Sernova's Court to Promote!
The ball is clearly in Sernova's court for top level promotion to assist the share price once the PP closes. This implies irrefutable world class news on progression with The Pouch and hopefully long awaited collaborations with Big Pharma!
Keep in mind that tax loss selling season is coming. Unless Sernova can get matters moving soonish after the PP closes, the share price is likely to be under pressure again.
Further, if Sernova were (Subjunctive Case) to miss JDRF progress payments again because of any delay in the FDA trial, another PP could possibly be being talked about spring 2020.
There's much for Sernova to do in an expeditious manner.